Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.

PMID: 285922402017South Korea

Key Findings

The study identified several extended-spectrum beta-lactamase (ESBL) genes, including blaCTX-M-1, blaCTX-M-14, blaCTX-M-15, blaCTX-M-27, and blaSHV-2, which confer resistance to cefepime and piperacillin-tazobactam in Escherichia coli causing urinary tract infections.

View on PubMed

5gene entries

0mutation entries

AMR Genes

Gene Name	Alleles	Encodes	Confers Resistance To	Organisms	Database	Validation Status
blaCTX-M	4	beta-lactamase	Piperacillin/tazobactam	Escherichia coli	Reslit	-
blaSHV	1	beta-lactamase	Piperacillin/tazobactam	Escherichia coli	Reslit	-

Browse Papers

Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.

AMR Genes